Medicines Transparency Alliance (MeTA) : country progress and key lessons
Upcoming SlideShare
Loading in...5
×
 

Medicines Transparency Alliance (MeTA) : country progress and key lessons

on

  • 1,982 views

This presentation shares the progress to date of the pilot phase of the Medicines Transparency Alliance (MeTA) and was given by Wilbert Banneberg, Technical Director of the International MeTA ...

This presentation shares the progress to date of the pilot phase of the Medicines Transparency Alliance (MeTA) and was given by Wilbert Banneberg, Technical Director of the International MeTA Secretariat at the launch of MeTA Jordan in May 2009

Statistics

Views

Total Views
1,982
Slideshare-icon Views on SlideShare
1,978
Embed Views
4

Actions

Likes
0
Downloads
13
Comments
0

1 Embed 4

http://www.slideshare.net 4

Accessibility

Upload Details

Uploaded via as Microsoft PowerPoint

Usage Rights

© All Rights Reserved

Report content

Flagged as inappropriate Flag as inappropriate
Flag as inappropriate

Select your reason for flagging this presentation as inappropriate.

Cancel
  • Full Name Full Name Comment goes here.
    Are you sure you want to
    Your message goes here
    Processing…
Post Comment
Edit your comment
  • Title of presentation 10/06/09 MeTA

Medicines Transparency Alliance (MeTA) : country progress and key lessons Medicines Transparency Alliance (MeTA) : country progress and key lessons Presentation Transcript

  • Wilbert Bannenberg Technical Director International MeTA Secretariat 30 May 2009, Amman, Jordan Medicines Transparency Alliance (MeTA): Country progress and key lessons MeTA 16/09/2008
  • What is MeTA?
    • An innovative and comprehensive approach
    • An international & national multi-stakeholder alliance designed to:
      • support country efforts to increase access to medicines across the whole supply chain
      • improve the flow of information and increase transparency on price, quality, availability and promotion
      • support stronger governance and accountability and share learning
    16/09/2008 MeTA
  • MeTA Principles
    • Commitment to improving health
    • Comprehensive approach to health systems, including pharmaceuticals
    • Transparency and accountability can:
      • Improve system performance
      • Build confidence
      • Support equity and social justice
    • It takes us all working together to bring about the change we need
    16/09/2008 MeTA
  • MeTa Country commitments
    • Establish an effective multi-stakeholder forum with public, private and civil society engagement
    • Progressive disclosure of data in four areas
    • Quality Regulatory, sourcing, quality assurance, vigilance
      • Availability Supply chain operations, equitable access
      • Price Supplier, wholesaler, retailer, import taxes, duties, affordability
      • Promotion Objective information, rational use, ethical advertising
    16/09/2008 MeTA
  • MeTA Pilot Countries 16/09/2008 MeTA
  • MeTA Pilot objectives
    • Add value to country ATM efforts through transparency and multi-stakeholder working
    • Road test the MeTA approach in different country settings
    • Engage stakeholders at country and int’l levels
    • Provide a model for eventual roll out in further countries
    16/09/2008 MeTA
  • MeTA implementation process Stakeholders engaged MeTA Council formed MeTA Secretariat formed Pre-MoU work done MoU signed Work started GHANA JORDAN KYRGYZSTAN PERU PHILIPPINES UGANDA ZAMBIA 16/09/2008 MeTA
  • Specific Success or Milestone 16/09/2008 GHANA JORDAN KYRGYZSTAN PERU PHILIPPINES UGANDA ZAMBIA Establishment of the physical secretariat Full support of government and private sector Identifying the stakeholders and approval of the work plan Sign MoU because it is final point Successful forums and especially the CSO Forum in Jan 2009 Successful launch and the receiving of funds Successful launch and media interest
  • Key Challenges to MeTA implementation
    • Stakeholder engagement and maintaining interest
    • Insufficient legislation/regulation and excessive bureaucracy
    • Difficulties in extracting information
    • Lack of tools for accessing information
    16/09/2008 MeTA
  • Lessons learned in countries
    • Contexts are different in every country, so local conditions determine the pace and content of the work.
    • It takes time to get the right people at the table, build trust and develop a working relationship among stakeholders.
    • Consensus builds with a constant exchange of views.
    • Stakeholder commitment is key to a successful process.
    • Some problems in the medicines supply chain require tough political action to solve. Starting work on less controversial issues is key.
    • Systems and structures for disclosing data often do not exist in countries and may have to be created.
    16/09/2008 MeTA
  • Key priorities for MeTA
    • Progressive disclosure of data about medicines
    • Developing and testing a new multi-stakeholder approach and preparing stakeholders for meaningful engagement
    • Ensuring the strong engagement of the private sector at country and international level
    • Increasing the voice of patients and consumers and strengthening capacity and opportunity for their engagement
    • Documenting innovation, change and good practice across the programme.
    16/09/2008 MeTA
    • Congratulations to Jordan on the successful establishment and launch of MeTA and every good wish for the success of the programme here.
    • International Secretariat, [email_address]
    • www.MedicinesTransparency.org
    16/09/2008 MeTA